Next Article in Journal / Special Issue
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners
Previous Article in Journal
Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies
Previous Article in Special Issue
Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessReview
Cancers 2018, 10(2), 50; https://doi.org/10.3390/cancers10020050

Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis

1
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, Japan
2
Department of Gastroenterology, Katsuragi Hospital, Kishiwada 596-0825, Japan
3
Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan
*
Author to whom correspondence should be addressed.
Received: 14 January 2018 / Revised: 9 February 2018 / Accepted: 12 February 2018 / Published: 15 February 2018
(This article belongs to the Special Issue Latest Development in Pancreatic Cancer)
Full-Text   |   PDF [1486 KB, uploaded 22 February 2018]   |  

Abstract

The most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. However, these treatments result in inadequate pain control or drug-related adverse effects in some patients. An alternative pain-relief modality is celiac plexus neurolysis, in which the celiac plexus is chemically ablated. This procedure was performed percutaneously or intraoperatively until 1996, when endoscopic ultrasound (EUS)-guided celiac plexus neurolysis was first described. In this transgastric anterior approach, a neurolytic agent is injected around the celiac trunk under EUS guidance. The procedure gained popularity as a minimally invasive approach and is currently widely used to treat pancreatic cancer-associated pain. We focus on two relatively new techniques of EUS-guided neurolysis: EUS-guided celiac ganglia neurolysis and EUS-guided broad plexus neurolysis, which have been developed to improve efficacy. Although the techniques are safe and effective in general, some serious adverse events including ischemic and infectious complications have been reported as the procedure has gained widespread popularity. We summarize reported clinical outcomes of EUS-guided neurolysis in pancreatic cancer (from the PubMed and Embase databases) with a goal of providing information useful in developing strategies for pancreatic cancer-associated pain alleviation. View Full-Text
Keywords: endoscopic ultrasound; EUS; EUS-guided neurolysis; neurolysis; interventional EUS; pancreatic cancer; pain endoscopic ultrasound; EUS; EUS-guided neurolysis; neurolysis; interventional EUS; pancreatic cancer; pain
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Minaga, K.; Takenaka, M.; Kamata, K.; Yoshikawa, T.; Nakai, A.; Omoto, S.; Miyata, T.; Yamao, K.; Imai, H.; Sakamoto, H.; Kitano, M.; Kudo, M. Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis. Cancers 2018, 10, 50.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top